Martin Edwards - 20 Nov 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Martin Edwards
Issuer symbol
VRNA
Transactions as of
20 Nov 2023
Net transactions value
+$61,973
Form type
4
Filing time
22 Nov 2023, 17:09:08 UTC
Previous filing
15 Nov 2023
Next filing
30 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Purchase $61,973 +33,736 +30% $1.84* 144,800 20 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of 144,800 Ordinary Shares represented by 18,100 ADSs.